PharmaLectures.com

Courses › Pharma industry foundations › Who decides what in Brussels: EMA, national agencies, EDQM and the Commission, untangled

Who decides what in Brussels: EMA, national agencies, EDQM and the Commission, untangled

Your team files with the right European body the first time and launches on schedule.

  • 6 audio modulesthree lengths each
  • 1 h to 5 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • All staffwho it is written for

Why this training matters

A variation goes to the European Medicines Agency on Monday. Three weeks later a reply says it belongs with a national competent authority. The submission window closes, the launch date slips, and your commercial team asks why nobody knew.

What changes after this course

Your staff look at the product and the change, then name the right authority on the spot. Submissions stop bouncing between bodies. You hold a certificate for each learner and a training record per person, ready when an auditor asks.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory affairs team settles the lead authority in one meeting. They check the product against the mandatory scope of Regulation (EC) No 726/2004, then either file centrally with the European Medicines Agency or pick a Reference Member State for the decentralised procedure. Nobody waits for an outside adviser to say which door to knock on.

At the next audit, the quality manager opens the supplier file and finds the Certificate of Suitability issued by the European Directorate for the Quality of Medicines & HealthCare. It ties the material to its European Pharmacopoeia monograph, and the inspector's question is answered with one document instead of a folder of correspondence.

Clinical sponsors file once. Under the Clinical Trials Regulation (EU) No 536/2014, a single application through the Clinical Trials Information System reaches every Member State concerned, with a reporting Member State leading the assessment. Your clinical team stops drafting country-by-country packages and builds one dossier that survives validation.

A national inspector quotes a local rule, and your compliance lead does not freeze. They trace it to the national law transposing Directive 2001/83/EC or to the relevant volume of EudraLex, such as Volume 4 on good manufacturing practice, and put that reference in the written reply to the finding.

Who needs this training

  • Regulatory Affairs Specialist

    Before sending a variation, you check which authority owns it and send it there. No more weeks lost because a decentralised procedure question went to the European Medicines Agency instead of the Reference Member State.

  • Quality Assurance Manager

    When you qualify a new active ingredient supplier, you know whether a Certificate of Suitability exists and which European Pharmacopoeia monograph it must match, before the site visit and not during it.

  • Clinical Development Professional

    You write the protocol and the application with the Clinical Trials Regulation (EU) No 536/2014 in mind, so the reporting Member State can validate it without sending back requests for missing documents.

  • Market Access Manager

    You give the commercial team a launch date built on the real sequence from positive opinion to European Commission decision, not on a hopeful guess made in the planning meeting.

  • Pharmacovigilance Officer

    You know which safety data the EMA's Pharmacovigilance Risk Assessment Committee and the Committee for Medicinal Products for Human Use look for, and you deliver it in the form the agency expects, so fewer questions come back.

Roles: every role in the company

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Decide in one sitting whether a new product goes through the centralised, decentralised or mutual recognition procedure.
  2. Explain to a colleague what the Reference Member State does in a decentralised procedure and why its choice matters.
  3. Check a Certificate of Suitability against its European Pharmacopoeia monograph and spot when a supplier's certificate is at risk.
  4. List the steps between a positive opinion and the European Commission decision, and give Sales a realistic plan.
  5. Submit one clinical trial application through the Clinical Trials Information System for all Member States concerned.
  6. Trace a national inspector's rule back to Directive 2001/83/EC or EudraLex and cite it in a written reply.

What the company gets

  • Submissions reach the right authority the first time, so validation does not stall on a filing that was sent to the wrong place.
  • Each employee who handles European approvals has a certificate and a training record, so an auditor sees the history at once.
  • Supply stays steady because variations go to the correct national competent authority before a submission window closes.
  • Commercial plans use the real path from positive opinion to Commission decision, so launch dates stop being guesses.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 6 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard2 h 30 min25 min a module, for regulatory, quality and business-development staff
Expanded5 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing1 h
Business development and export salesBriefing1 h
Finance, pricing and tendersBriefing1 h
Marketing and communicationsBriefing1 h
Human resources and onboardingBriefing1 h
IT, data and validationBriefing1 h
Regulatory affairsStandard2 h 30 min
Quality assurance and Qualified PersonStandard2 h 30 min
Quality control and laboratoryStandard2 h 30 min
Production and engineeringStandard2 h 30 min
Supply chain, purchasing and logisticsStandard2 h 30 min
Pharmacovigilance and medicalStandard2 h 30 min

Course outline: 6 modules

6 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Trace any dossier question back to Directive 2001/83/EC

    • How to find the Directive 2001/83/EC article behind a dossier question before you email legal.
    • Why a centralised authorisation also covers Norway, Iceland and Liechtenstein.
    • What the European Commission decides on your authorisation after launch, so no notice catches you cold.
  2. 2Decide when a product must go to the European Medicines Agency

    • The test that tells you in one minute whether a new therapy must go the centralised route.
    • What the Committee for Medicinal Products for Human Use checks before it gives a positive opinion.
    • How to shape pharmacovigilance data for the agency so the list of questions comes back shorter.
  3. 3Run decentralised and mutual recognition filings with national agencies

    • How to choose a Reference Member State and why that choice sets the pace of the whole procedure.
    • What to do when national agencies disagree during mutual recognition, and who settles it.
    • When to call the national agency directly and when the European Medicines Agency is the wrong inbox.
  4. 4Use European Pharmacopoeia standards to qualify your active ingredients

    • How a Certificate of Suitability saves you from rewriting the active ingredient section.
    • Which European Pharmacopoeia monograph your incoming material must meet, and where to find it.
    • Why an inspection finding can suspend a supplier's Certificate of Suitability, and how to see it coming.
  5. 5Follow a positive opinion to the final European Commission decision

    • The steps between a positive opinion and the Commission decision, so Sales gets a date it can trust.
    • How a positive opinion becomes a Commission decision, and where the CMDh settles disputes between Member States in mutual recognition and decentralised procedures.
    • Where an agency guideline stands when a local inspector challenges it, and what you can say back.
  6. 6Prepare studies for the Clinical Trials Regulation (EU) No 536/2014

    • How to file one application through the Clinical Trials Information System instead of one per country.
    • What the reporting Member State checks first, so your application passes validation without queries.
    • Why the Pharmaceutical Strategy for Europe belongs in your pipeline plan before it reaches your desk.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

6 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h in the briefing length and 5 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for All staff. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 54 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team